Lung cancer drug shows promise against brain metastases
Disease control
Completed
This study tested the drug osimertinib (Tagrisso) in 73 patients with a specific type of lung cancer that had spread to the lining of the brain and spinal cord (leptomeningeal metastases). Patients took one 80 mg tablet daily. The goal was to see if the drug could improve overall…
Phase: PHASE2 • Sponsor: Sehhoon Park • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC